Literature DB >> 25799897

IL-1β, IL-6 and IL1Ra levels in temporal lobe epilepsy.

Irem Fatma Uludag1, Tarik Duksal2, Bedile Irem Tiftikcioglu2, Yasar Zorlu2, Feriha Ozkaya3, Guldal Kirkali3.   

Abstract

PURPOSE: There is now extensive evidence to support the involvement of inflammation in the course of epileptic seizures. Seizure-induced changes in serum IL-1β, IL-6 and IL-1Ra levels are reported in several studies. Serum cytokine levels may also be disturbed in inter-ictal period due to seizure activity.
METHODS: Twenty-one patients (12 women; mean age 35±12.3) with temporal lobe epilepsy (TLE), 17 patients (8 women; mean age 31.8±10.4) with extra-temporal lobe epilepsy (XLE) and 20 normal controls (10 women; mean age 35.6±8.8) were included in the study. Serum levels of IL-1β, IL-6 and IL-1Ra of the TLE, XLE groups in inter-ictal period and of the normal control group were compared.
RESULTS: All three cytokine levels are found to be significantly elevated in epilepsy patients when compared to controls (p<0.05). In TLE group, IL-1β serum levels were significantly higher than in the XLE group (p<0001).
CONCLUSION: The major findings in our study were increased levels of IL-1β, IL-6 and IL-1Ra in epileptic patients and high levels of IL-1β in TLE group. Our results support the existence of a chronic inflammatory state in epileptic patients.
Copyright © 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytokines; Epilepsy; IL-1Ra; IL-1β; IL-6; Temporal lobe epilepsy

Mesh:

Substances:

Year:  2015        PMID: 25799897     DOI: 10.1016/j.seizure.2015.01.009

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  30 in total

Review 1.  Infections, inflammation and epilepsy.

Authors:  Annamaria Vezzani; Robert S Fujinami; H Steve White; Pierre-Marie Preux; Ingmar Blümcke; Josemir W Sander; Wolfgang Löscher
Journal:  Acta Neuropathol       Date:  2015-09-30       Impact factor: 17.088

2.  Gastrodin Attenuates Pentylenetetrazole-Induced Seizures by Modulating the Mitogen-Activated Protein Kinase-Associated Inflammatory Responses in Mice.

Authors:  Liming Chen; Xinan Liu; Hua Wang; Min Qu
Journal:  Neurosci Bull       Date:  2016-12-01       Impact factor: 5.203

3.  Anticonvulsant Effect of Swertiamarin Against Pilocarpine-Induced Seizures in Adult Male Mice.

Authors:  Xian-Hua Deng; Xiao Zhang; Jing Wang; Peng-Sheng Ma; Lin Ma; Yang Niu; Tao Sun; Ru Zhou; Jian-Qiang Yu
Journal:  Neurochem Res       Date:  2017-07-05       Impact factor: 3.996

4.  Treatment of Inflammatory Diseases with IL-1 Blockade.

Authors:  Charles A Dinarello
Journal:  Curr Otorhinolaryngol Rep       Date:  2018-03-07

Review 5.  Neuroinflammation and Proinflammatory Cytokines in Epileptogenesis.

Authors:  Alireza Soltani Khaboushan; Niloufar Yazdanpanah; Nima Rezaei
Journal:  Mol Neurobiol       Date:  2022-01-11       Impact factor: 5.590

Review 6.  GABA-ergic cell therapy for epilepsy: Advances, limitations and challenges.

Authors:  Ashok K Shetty; Dinesh Upadhya
Journal:  Neurosci Biobehav Rev       Date:  2015-12-31       Impact factor: 8.989

Review 7.  Overview of the IL-1 family in innate inflammation and acquired immunity.

Authors:  Charles A Dinarello
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

8.  CB2 receptors modulate seizure-induced expression of pro-inflammatory cytokines in the hippocampus but not neocortex.

Authors:  Anna A Karan; Yulia S Spivak; Konstantin A Gerasimov; Elena M Suleymanova; Maria N Volobueva; Alexey A Kvichansky; Lyudmila V Vinogradova; Alexey P Bolshakov
Journal:  Mol Neurobiol       Date:  2021-04-27       Impact factor: 5.590

9.  IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy.

Authors:  Antonio Leo; Valentina Nesci; Martina Tallarico; Nicola Amodio; Eugenia M Gallo Cantafio; Giovambattista De Sarro; Andrew Constanti; Emilio Russo; Rita Citraro
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

10.  Chemistry, Pharmacology and Therapeutic Potential of Swertiamarin - A Promising Natural Lead for New Drug Discovery and Development.

Authors:  Nur Sakinah Muhamad Fadzil; Mahendran Sekar; Siew Hua Gan; Srinivasa Reddy Bonam; Yuan Seng Wu; Jaishree Vaijanathappa; Subban Ravi; Pei Teng Lum; Shivsharan B Dhadde
Journal:  Drug Des Devel Ther       Date:  2021-06-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.